Tumorigenesis, proliferation, apoptosis and cell migration were also assessed both in vivo and in vitro, and the results demonstrated that aberrant expression of GSK3β served as an independent indicator of poor prognosis for NSCLC. This evidence concerns the gene GSK3B and non-small cell lung carcinoma.